An integrated strategy for the discovery of drug targets by the analysis of protein-protein interactions

被引：3

作者：

Peltier, JM ^{[1
]}

Askovic, S ^{[1
]}

Becklin, RR ^{[1
]}

Chepanoske, CL ^{[1
]}

Ho, YSJ ^{[1
]}

Kery, V ^{[1
]}

Lai, SP ^{[1
]}

Mujtaba, T ^{[1
]}

Pyne, M ^{[1
]}

Robbins, PB ^{[1
]}

von Rechenberg, M ^{[1
]}

Richardson, B ^{[1
]}

Savage, J ^{[1
]}

Sheffield, P ^{[1
]}

Thompson, S ^{[1
]}

Weir, L ^{[1
]}

Widjaja, K ^{[1
]}

Xu, NF ^{[1
]}

Zhen, YJ ^{[1
]}

Boniface, JJ ^{[1
]}

机构：

[1] Prolexys Pharmaceut Inc, Salt Lake City, UT 84116 USA

来源：

INTERNATIONAL JOURNAL OF MASS SPECTROMETRY | 2004年 / 238卷 / 02期

关键词：

protein interactions; MS/MS; affinity tags; drug discovery; drug targets;

D O I：

10.1016/j.ijms.2003.12.039

中图分类号：

O64 [物理化学（理论化学）、化学物理学]; O56 [分子物理学、原子物理学];

学科分类号：

070203 ; 070304 ; 081704 ; 1406 ;

摘要：

Proteomics-based technologies have the potential to accelerate the development of drugs, but such technologies must be well integrated in order to have a positive impact. We describe, herein, a multi-step process for the discovery of protein-protein interactions. It is shown that process stages are interdependent and can influence, either positively or negatively, subsequent steps. Optimization of each step, in the context of the full process, is essential for the overall success of the experiment. (C) 2004 Elsevier B.V. All rights reserved.

引用

页码：119 / 130

页数：12

共 50 条

[21] Inhibition of Protein-protein Interactions in Plasmodium falciparum: Future Drug Targets
Pierrot, Christine
Freville, Aline
Olivier, Christophe
Souplet, Vianney
Khalife, Jamal
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (24) : 3522 - 3530
[22] Integrated network analysis platform for protein-protein interactions
Wu, Jianmin
Vallenius, Tea
Ovaska, Kristian
Westermarck, Jukka
Makela, Tomi P.
Hautaniemi, Sampsa
NATURE METHODS, 2009, 6 (01) : 75 - 77
[23] Integrated network analysis platform for protein-protein interactions
Wu J.
Vallenius T.
Ovaska K.
Westermarck J.
Mäkelä T.P.
Hautaniemi S.
Nature Methods, 2009, 6 (1) : 75 - 77
[24] Breaking the spell: drug discovery based on modulating protein-protein interactions
Strosberg, AD
EXPERT REVIEW OF PROTEOMICS, 2004, 1 (02) : 141 - 143
[25] Targeting Protein-Protein Interactions and Fragment-Based Drug Discovery
Valkov, Eugene
Sharpe, Tim
Marsh, May
Greive, Sandra
Hyvoenen, Marko
FRAGMENT-BASED DRUG DISCOVERY AND X-RAY CRYSTALLOGRAPHY, 2012, 317 : 145 - 179
[26] PROTEIN-PROTEIN INTERACTIONS AS NEW TARGETS FOR DRUG DESIGN: VIRTUAL AND EXPERIMENTAL APPROACHES
Ivanov, Alexis S.
Gnedenko, Oksana V.
Molnar, Andrey A.
Mezentsev, Yury V.
Lisitsa, Andrey V.
Archakov, Alexander I.
JOURNAL OF BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, 2007, 5 (2B) : 579 - 592
[27] Modeling protein-protein interactions for interaction targets
Nussinov, Ruth
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
[28] Protein-protein interactions as targets for antiviral chemotherapy
Loregian, A
Marsden, HS
Palù, G
REVIEWS IN MEDICAL VIROLOGY, 2002, 12 (04) : 239 - 262
[29] Protein-protein interactions as therapeutic targets in neuropsychopharmacology
Reilly, Matthew T.
Cunningham, Kathryn A.
Natarajan, Amarnath
NEUROPSYCHOPHARMACOLOGY, 2009, 34 (01) : 247 - 248
[30] Small molecules, big targets: drug discovery faces the protein-protein interaction challenge
Scott, Duncan E.
Bayly, Andrew R.
Abell, Chris
Skidmore, John
NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (08) : 533 - 550

← 1 2 3 4 5 →